Dacarbazine induced acute myeloid leukemia in melanoma.

Treatment-related acute myeloid leukemia (tAML) is a rarely reported complication of therapy of melanoma. In fact, there are only four cases of tAML or myelodysplastic syndrome (MDS) in chemotherapy treated melanoma patients reported in English literature. Two cases implicated either fotemustine or